ES8107300A1 - Un metodo para la preparacion de una composicion de virus herpes - Google Patents

Un metodo para la preparacion de una composicion de virus herpes

Info

Publication number
ES8107300A1
ES8107300A1 ES482549A ES482549A ES8107300A1 ES 8107300 A1 ES8107300 A1 ES 8107300A1 ES 482549 A ES482549 A ES 482549A ES 482549 A ES482549 A ES 482549A ES 8107300 A1 ES8107300 A1 ES 8107300A1
Authority
ES
Spain
Prior art keywords
preparation
herpes
herpes virus
virus
virus vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482549A
Other languages
English (en)
Spanish (es)
Other versions
ES482549A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES482549A0 publication Critical patent/ES482549A0/es
Publication of ES8107300A1 publication Critical patent/ES8107300A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
ES482549A 1978-07-21 1979-07-17 Un metodo para la preparacion de una composicion de virus herpes Expired ES8107300A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92706978A 1978-07-21 1978-07-21

Publications (2)

Publication Number Publication Date
ES482549A0 ES482549A0 (es) 1980-12-16
ES8107300A1 true ES8107300A1 (es) 1980-12-16

Family

ID=25454121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES482549A Expired ES8107300A1 (es) 1978-07-21 1979-07-17 Un metodo para la preparacion de una composicion de virus herpes

Country Status (12)

Country Link
EP (1) EP0008255B1 (en:Method)
JP (1) JPS5519271A (en:Method)
AT (1) ATE3058T1 (en:Method)
AU (1) AU532186B2 (en:Method)
DE (1) DE2965191D1 (en:Method)
DK (1) DK306379A (en:Method)
ES (1) ES8107300A1 (en:Method)
HU (1) HU182530B (en:Method)
IE (1) IE48379B1 (en:Method)
PL (1) PL217216A1 (en:Method)
PT (1) PT69953A (en:Method)
RO (1) RO76563A2 (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
FR2804026B1 (fr) 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
EP3246400B1 (en) 2012-01-09 2019-10-23 Sanofi Pasteur Biologics, LLC Purification of herpes virus
WO2013177172A2 (en) 2012-05-21 2013-11-28 Sanofi Pasteur Limited Herpesvirus compositions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof

Also Published As

Publication number Publication date
AU532186B2 (en) 1983-09-22
JPS6332768B2 (en:Method) 1988-07-01
DE2965191D1 (en) 1983-05-19
EP0008255A1 (en) 1980-02-20
AU4882079A (en) 1980-01-24
ES482549A0 (es) 1980-12-16
PL217216A1 (en:Method) 1980-12-15
JPS5519271A (en) 1980-02-09
IE48379B1 (en) 1984-12-26
PT69953A (en) 1979-08-01
RO76563A2 (ro) 1981-04-30
HU182530B (en) 1984-01-30
DK306379A (da) 1980-01-22
EP0008255B1 (en) 1983-04-13
ATE3058T1 (de) 1983-04-15

Similar Documents

Publication Publication Date Title
ES2179105T3 (es) Adyuvantes proteinicos.
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
NO170126C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater i form av suspensjoner som inneholder sucralfat
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ES477653A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoazucares.
SE8601709L (sv) Farmaceutiskt medel samt komposition innehallande detta
ES487676A1 (es) Procedimiento para la preparacion de un reactivo para la de-terminacion de la lipasa
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
ES2035818T3 (es) Mutantes de delecion de la timidin-kinasa del virus del herpes bovino-1, vacunas contra la rinotraqueitis bovina infecciosa que los contienen y metodos para su produccion y uso.
ES2061696T3 (es) Tratamiento de las mastitis y aplicador para el mismo.
ES2031883T3 (es) Un metodo para preparar una combinacion antiviral.
FI843560A7 (fi) Mevalonolaktonin analogeja ja niiden johdannaisia, menetelmiä niiden valmistamiseksi, niitä sisältäviä farmaseuttisia yhdistelmiä ja niide n käyttö farmaseuttisina aineina.
GB1546027A (en) Stabilised thymosin fraction and a method for the preparation of same
ES8107300A1 (es) Un metodo para la preparacion de una composicion de virus herpes
ES2032339T3 (es) Procedimiento para preparar nuevos compuestos de indolilpiperidina.
PT88150A (pt) Processo para a preparacao de uma composicao farmaceutica combinada contendo um polissacarido sulfatado e um derivado de xantina
MX9203371A (es) Substancias secas obtenibles por liofilizacion para la preparacion de suspensiones estables.
ES2050651T3 (es) Medicamento transdermal.
ATE59778T1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
ES2000435A4 (es) Procedimiento de purificacion de antigenos proteinicos de bacterias que pertenecen al genero bordetella, en vista a la obtencion de una vacuna acelular.
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
ES2043884T3 (es) Metodo de gran rendimiento para la preparacion de algodon a partir de celulas cultivadas.
Breese Jr et al. Electron microscopy of African swine fever virus hemadsorption
IT8019770A0 (it) Derivati della benzammidina, procedimento per la loro preparazione e composizioni fungicide che li contengono.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303